Zai Lab Ltd

Company Profile

Zai Lab Ltd had its IPO on 2017-09-20 under the ticker symbol ZLAB.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Zai Lab Ltd has a staff strength of 0 employees.

Stock update

Shares of Zai Lab Ltd opened at $26 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $25.6 - $28.39, and closed at $27.43.

This is a +9.63% increase from the previous day's closing price.

A total volume of 947,926 shares were traded at the close of the day’s session.

In the last one week, shares of Zai Lab Ltd have increased by +14.29%.

Zai Lab Ltd's Key Ratios

Zai Lab Ltd has a market cap of $2.686 billion, indicating a price to book ratio of 1.8 and a price to sales ratio of 14.74.

In the last 12-months Zai Lab Ltd’s revenue was $0.182 billion with a gross profit of $-0.481 billion and an EBITDA of $-0.473 billion. The EBITDA ratio measures Zai Lab Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Zai Lab Ltd’s operating margin was -264% while its return on assets stood at -18.1% with a return of equity of -36.7%.

In Q2, Zai Lab Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 30.4%.

Zai Lab Ltd’s PE and PEG Ratio

Forward PE

-

Trailing PE

-

PEG

None

Its diluted EPS in the last 12-months stands at $-5.84 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Zai Lab Ltd’s profitability.

Zai Lab Ltd stock is trading at a EV to sales ratio of 5.59 and a EV to EBITDA ratio of -2.137. Its price to sales ratio in the trailing 12-months stood at 14.74.

Zai Lab Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Zai Lab Ltd ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Zai Lab Ltd ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Zai Lab Ltd’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Zai Lab Ltd's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Zai Lab Ltd paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$27.43

52-Week High

$102.43

52-Week Low

$20.98

Analyst Target Price

$92.02

Zai Lab Ltd stock is currently trading at $27.43 per share. It touched a 52-week high of $102.43 and a 52-week low of $102.43. Analysts tracking the stock have a 12-month average target price of $92.02.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.